Advertisement
Home Tags Cancer: Breast

Tag: Cancer: Breast

Estimating Breast Cancer Risk

Breast Cancer Risk Up With Dense Breasts, Benign Breast Disease

0

Elevated risk also seen for benign breast disease and fatty breasts and extremely dense breasts without benign breast disease

Impact of Pandemic Projected for U.S. Breast Cancer Mortality

Digital Breas​t Tomosynthesis Tool Can Help Predict Breast Cancer

0

DBT-based risk model can predict cancer after a negative screening exam, with high discriminative performance for one-year risk

Smiling physiotherapist  taking care of the happy senior patient in wheelchair

Having MS May Impact Cancer Screening, Diagnosis

0

Patients with multiple sclerosis and breast cancer less likely to have screen-detected breast cancer

Vitamin D Level, Race/Ethnicity Tied to Breast Cancer Risk

0

Sufficient circulating vitamin D concentration linked to lower risk for breast cancer in Hispanic/Latina women

Adding Ribociclib to Letrozole Prolongs Survival in Advanced Breast Cancer

0

Reduced risk for death seen with letrozole plus ribociclib versus placebo in postmenopausal women with HR-positive, HER2-negative disease

Family Breast Cancer History Tied to Breast Density on Mammo

0

Authors say findings show the need to start annual screening earlier in premenopausal women with a family history of breast cancer

Patients Confused, Concerned About Diagnosis, Treatment of DCIS

0

In web-based survey, participants expressed concern about 'cancer spreading' or becoming invasive, not doing enough to prevent recurrence

Daily Aspirin Does Not Prevent Recurrence of Breast Cancer

0

Compared with placebo, daily aspirin did not improve invasive disease-free survival in patients with high-risk, HER2-negative breast cancer

Aromatase Inhibitors May Benefit Premenopausal Women With Breast Cancer

0

For premenopausal women receiving ovarian suppression, risk for breast cancer recurrence reduced with aromatase inhibitor versus tamoxifen

Neoadjuvant Pembrolizumab Plus Chemo Treats Early TNBC

0

Rate of event-free survival higher with neoadjuvant pembrolizumab plus chemo versus chemo alone for early triple-negative breast cancer